James P. Kemp

10.0k total citations
107 papers, 3.7k citations indexed

About

James P. Kemp is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, James P. Kemp has authored 107 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Physiology, 70 papers in Pulmonary and Respiratory Medicine and 22 papers in Immunology and Allergy. Recurrent topics in James P. Kemp's work include Asthma and respiratory diseases (78 papers), Respiratory and Cough-Related Research (50 papers) and Inhalation and Respiratory Drug Delivery (38 papers). James P. Kemp is often cited by papers focused on Asthma and respiratory diseases (78 papers), Respiratory and Cough-Related Research (50 papers) and Inhalation and Respiratory Drug Delivery (38 papers). James P. Kemp collaborates with scholars based in United States, United Kingdom and France. James P. Kemp's co-authors include Robert J. Dockhorn, Theodore F. Reiss, David S. Pearlman, Edwin A. Bronsky, Beth C. Seidenberg, H.Alice Orgel, Leslie Hendeles, Jay Grossman, Jonathan A. Leff and Ji Zhang and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

James P. Kemp

101 papers receiving 3.4k citations

Peers

James P. Kemp

PHYSI

PRM

PPCH

Paul Chervinsky United States

Edwin A. Bronsky United States

Don Cockcroft Canada

William W. Storms United States

ST Holgate United Kingdom

T Kava Finland

Christopher H. Fanta United States

K. F. Kerrebijn Netherlands

Erika Sims United Kingdom

Peter König United States

Paul Chervinsky United States

James P. Kemp

3.1k ×1.0

PHYSI

2.3k ×1.0

PRM

1.2k ×1.3

145 ×0.6

201 ×1.0

PPCH

Citations per year, relative to James P. Kemp James P. Kemp (= 1×) peers Paul Chervinsky

Countries citing papers authored by James P. Kemp

Since Specialization

Citations

This map shows the geographic impact of James P. Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. Kemp more than expected).

Fields of papers citing papers by James P. Kemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. Kemp. The network helps show where James P. Kemp may publish in the future.

Co-authorship network of co-authors of James P. Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of James P. Kemp. A scholar is included among the top collaborators of James P. Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. Kemp. James P. Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kemp, James P., et al.. (2024). Directed stochasticity: Building biomolecular condensates in the right place. The Journal of Cell Biology. 224(1).

Kemp, James P., et al.. (2023). Histone locus bodies: a paradigm for how nuclear biomolecular condensates control cell cycle regulated gene expression. Nucleus. 14(1). 2293604–2293604. 15 indexed citations

Kemp, James P., Xiaocui Yang, Zbigniew Domiński, William F. Marzluff, & Robert J. Duronio. (2021). Superresolution light microscopy of the Drosophila histone locus body reveals a core–shell organization associated with expression of replication–dependent histone genes. Molecular Biology of the Cell. 32(9). 942–955. 15 indexed citations

Kupiec, Thomas C, et al.. (2011). A Fatality Due to an Accidental Methadone Substitution in a Dental Cocktail. Journal of Analytical Toxicology. 35(7). 512–515. 4 indexed citations

Kemp, James P.. (2009). Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist. Therapeutics and Clinical Risk Management. 5. 923–923. 8 indexed citations

Kemp, James P., et al.. (2007). Evaluation of albuterol 1.25 mg and 0.62 mg for nebulization in 6- to 12-year-old children with moderately severe asthma. Advances in Therapy. 24(3). 463–477. 2 indexed citations

Leff, Jonathan A., William W. Busse, David S. Pearlman, et al.. (1999). Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction. Survey of Anesthesiology. 43(3). 185–186. 40 indexed citations

Kemp, James P., et al.. (1999). A 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholine☆☆☆★★★. Journal of Allergy and Clinical Immunology. 104(6). 1189–1197. 18 indexed citations

Kemp, James P., et al.. (1998). Safety and clinical efficacy of zileuton in patients with chronic asthma.. PubMed. 4(6). 841–8. 29 indexed citations

10.

Kemp, James P., David Cook, Gary A. Incaudo, et al.. (1998). Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Journal of Allergy and Clinical Immunology. 101(2). 188–195. 56 indexed citations

11.

Fish, James E., et al.. (1997). Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. Clinical Therapeutics. 19(4). 675–690. 130 indexed citations

12.

Bronsky, Edwin A., et al.. (1997). Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene–receptor antagonist, at the end of a once-daily dosing interval*. Clinical Pharmacology & Therapeutics. 62(5). 556–561. 68 indexed citations

13.

Bierman, C. Warren, et al.. (1996). Efficacy and Safety of Inhaled Bitolterol Mesylate Via Metered-Dose Inhaler in Children with Asthma. Annals of Allergy Asthma & Immunology. 76(1). 27–35. 3 indexed citations

14.

Bardana, Emil J., Jonathan A. Bernstein, Joann Blessing-Moore, et al.. (1995). Practice parameters for the diagnosis and treatment of asthma. Journal of Allergy and Clinical Immunology. 96. 707–870. 67 indexed citations

15.

Kemp, James P., Robert J. Dockhorn, William W. Busse, Eugene R. Bleecker, & Andre van As. (1994). Prolonged Effect of Inhaled Salmeterol against Exercise-Induced Bronchospasm. American Journal of Respiratory and Critical Care Medicine. 150(6). 1612–1615. 67 indexed citations

16.

Bronsky, Edwin A., James P. Kemp, H.Alice Orgel, et al.. (1994). A 1-Week Dose-Ranging Study of Inhaled Salmeterol in Patients With Asthma. CHEST Journal. 105(4). 1032–1037. 16 indexed citations

17.

Pearlman, David S., Paul Chervinsky, Craig LaForce, et al.. (1992). A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma. New England Journal of Medicine. 327(20). 1420–1425. 290 indexed citations

18.

Shapiro, Gail G., James P. Kemp, Richard G. DeJong, et al.. (1990). Effects of albuterol and procaterol on exercise-induced asthma.. PubMed. 65(4). 273–6. 14 indexed citations

19.

Welch, Michael J., James P. Kemp, C. Warren Bierman, et al.. (1989). Comparison of Bitolterol Mesylate and Isoproterenol by Metered-Dose Inhaler for Regular, Long-Term Treatment in Asthmatic Children. Pediatric Asthma Allergy & Immunology. 3(1). 27–36. 2 indexed citations

20.

Kemp, James P., Edwin A. Bronsky, Jay Grossman, et al.. (1989). Albuterol treatment for children with asthma: A comparison of inhaled powder and aerosol. Journal of Allergy and Clinical Immunology. 83(3). 697–702. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact